Leadership Appointments Support Global Expansion

Two strategic appointments announced by Concept Life Sciences has seen Dr Michael Donaldson take up the role as Principal Scientist in its Dermal department and Dr Tim Calvert as Vice President of Business Development, Integrated Discovery Services, Europe.

Tim, who has extensive experience in the delivery of integrated drug discovery and development solutions, joins from Aptuit where he held various roles, most recently Senior Director of Integrated Drug Development. He has also worked for Lonza, where he led and secured Israel’s first gene therapy development programme, Catalent Pharma Solutions and Invitrogen.

Michael has over 17 years’ experience in the pharmaceutical development and manufacturing industry. Most recently he was Director of Biology in Dermatology Therapy Area at GlaxoSmithKline. Previous experience includes formulation and manufacturing at Stiefel, a GSK company, development of skin permeation products at MedPharm and developing liquid chromatography methods for antibiotic production analysis within the QC/QA group at Roche Pharmaceuticals. In his new role at Concept, Michael will be responsible for Dermal Services.

Philip Payne, Chief Commercial Officer, Concept Life Sciences, said: “We are delighted to welcome Michael and Tim to Concept. Their notable scientific and commercial backgrounds will be invaluable in supporting the continued expansion of the group.”